Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,117.26 +10.18 (+0.92%)

Official Closing Price Updated: 4:10 PM EDT, Jun 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Buyer’s Remorse: Why the Early-Week Market Rally Collapsed into a Flight for Safety

March 20, 2026

The promise of a mid-March market recovery vanished this week as a short-lived "relief rally" gave way to a wave of "buyer’s remorse," leaving investors scrambling for cover. What began on Monday as a...

Via MarketMinute

My Top 3 Drug Stocks for March 2026 ↗

March 20, 2026

These companies have impressive track records of navigating the biggest challenges in their industry.

Via The Motley Fool

Topics Intellectual Property

2 Healthcare Stocks to Buy Before They Get Bought Out ↗

March 20, 2026

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

Via The Motley Fool

Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals ↗

March 19, 2026

Both have plenty to offer investors, but one has a better outlook.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17% ↗

March 19, 2026

Eli Lilly says retatrutide trial results show major weight loss and blood sugar improvements in the diabetes study.

Via Benzinga

Is It Too Late to Buy Eli Lilly? ↗

March 19, 2026

Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact.

Via The Motley Fool

Topics Intellectual Property

Should You Buy the Vanguard S&P 500 ETF After the Recent Stock Market Sell-Off? History Offers a Crystal-Clear Answer. ↗

March 19, 2026

Volatility in the stock market often leads to great long-term opportunities for investors.

Via The Motley Fool

Topics ETFs Economy Stocks

1 Reason I'm Never Selling Novo Nordisk Stock ↗

March 19, 2026

I am not turned off by the company's recent setbacks.

Via The Motley Fool

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial ↗

March 19, 2026

Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks.

Via Investor's Business Daily

AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown

March 18, 2026

The pharmaceutical giant AbbVie (NYSE: ABBV) experienced a sharp decline on Wednesday, March 18, 2026, as its stock price tumbled to its lowest level since mid-2025. Shares of the Illinois-based...

Via MarketMinute

Topics ETFs Economy Intellectual Property

Stock Of The Day: Is The Eli Lilly Selloff Over? ↗

March 18, 2026

Eli Lilly shares made a large move lower. But they are oversold and getting close to a level where there may be support.

Via Benzinga

Ardsley Dumps 440,000 Hut 8 Shares Worth $19.4 Million ↗

March 18, 2026

Hut 8 operates large-scale data centers supporting Bitcoin mining and high-performance computing for institutional clients.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

March 18, 2026

In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot

March 18, 2026

As of March 18, 2026, Hims & Hers Health (NYSE: HIMS) has reclaimed its position as the primary protagonist in the direct-to-consumer (DTC) healthcare narrative. Following a turbulent start to the year...

Via Finterra

Topics Intellectual Property

Members of Congress Bought These 5 Stocks—Should You? ↗

March 18, 2026

Via MarketBeat

Airlines Take Flight While Oil Burns: Markets Edge Higher Amid Middle East Tensions ↗

March 18, 2026

Via Chartmill

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)

March 17, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗

March 17, 2026

Each of these companies could benefit from this high-growth market over time.

Via The Motley Fool

Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move ↗

March 17, 2026

These companies are benefiting from a tidal wave of demand for new weight-loss drugs.

Via The Motley Fool

Topics Stocks

Stock Market Today, March 17: Markets Edge Upwards as Fed Meeting Opens ↗

March 17, 2026

Today, March 17, 2026, selective tech gains helped lift the Nasdaq even as oil prices and geopolitical tensions stayed elevated.

Via The Motley Fool

Topics Economy Stocks

Why Eli Lilly (LLY) Shares Are Plunging Today

March 17, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 6.3% in the afternoon session after investment bank HSBC downgraded the stoc...

Via StockStory

Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure ↗

March 17, 2026

You don't have to go all in to profit from AI.

Via The Motley Fool

Topics Artificial Intelligence

Which S&P500 stocks are moving on Tuesday? ↗

March 17, 2026

Via Chartmill

LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff ↗

March 17, 2026

The analyst’s new price target represents a potential downside of about 14% from the stock’s last closing price on Monday.

Via Stocktwits

Tuesday's session: top gainers and losers in the S&P500 index ↗

March 17, 2026

Via Chartmill

Why Eli Lilly Stock Just Dropped ↗

March 17, 2026

Eli Lilly's stock price is based on growth rates that might fall short.

Via The Motley Fool

Eli Lilly Analyst Flags Overhyped Obesity Drug Expectations ↗

March 17, 2026

HSBC downgrades Eli Lilly to reduce, citing pricing pressure, rising competition, and overestimated obesity drug market growth expectations.

Via Benzinga

Tuesday's session: gap up and gap down stock in the S&P500 index ↗

March 17, 2026

Via Chartmill

This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock ↗

March 17, 2026

Novo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development.

Via The Motley Fool

Should You Avoid Pfizer? Here's the Key Risk to Watch ↗

March 17, 2026

Pfizer has reached a turning point.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.